Best Fifty410 Alternatives for GLP-1 Treatment in 2026 — 2026

Last reviewed: September 11, 2026 Last updated: September 11, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Fifty410 holds a strong position in the 2026 compounded GLP-1 market, with month-to-month semaglutide injection at $199 and tirzepatide at $133–183/month equivalent when prepaid quarterly. PlexusDx undercuts that semaglutide rate by $10/month at $189 month-to-month, while Fifty410's tirzepatide prepaid tiers run $106–156/month below PlexusDx's $289 month-to-month tirzepatide—though the Fifty410 tirzepatide option requires a $399–549 upfront payment every three months and ships the entire supply at once. Among seven other checkout-verified alternatives captured July 2026, Eden delivers semaglutide at $198/month all-in (medication plus required membership), Peak Wellness at $249, and Embody, Found cash month-to-month, Henry Meds, and TrimRx range $289–299. For readers who prefer monthly flexibility and minimal upfront outlay, PlexusDx semaglutide and several alternatives beat Fifty410 on structure; for readers comfortable with quarterly prepayment and seeking the lowest effective monthly tirzepatide rate in our data set, Fifty410's starter tier is unmatched.

At-a-glance: Fifty410 vs alternatives

Key: MTM = month-to-month billing, no commitment. Prepaid equivalents are our calculation from documented upfront totals. All programs ship compounded medication; compounded medications are not FDA-approved and the FDA does not review them for safety, effectiveness, or quality before marketing. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Normalized pricing: month-to-month and twelve-month totals

Fifty410 offers two structures. Compounded semaglutide injection bills $199 each month with no contract. Compounded tirzepatide injection ships a three-month supply upfront at three price tiers: starter ($399 upfront, or $133/month equivalent when prepaid for three months—our calculation), mid dose ($499 upfront, or $166/month equivalent when prepaid for three months—our calculation), and high dose ($549 upfront, or $183/month equivalent when prepaid for three months—our calculation). Consultation, medication, and shipping are included; there is no membership fee. Older help-center documentation shows different tiers; we use the pricing-page figures captured September 4, 2026, and recommend confirming at checkout.

Semaglutide injection over twelve months

• Fifty410: $199/month × 12 = $2,388
• PlexusDx: $189/month × 12 = $2,268 (saves $120/year, or $10/month—our calculation)
• Eden: $198/month × 12 = $2,376 (saves $12/year vs Fifty410—our calculation)
• Peak Wellness: $249/month × 12 = $2,988
• Found (cash MTM): $289/month × 12 = $3,468
• Henry Meds: $297/month × 12 = $3,564
• Embody: $299/month × 12 = $3,588
• TrimRx (checkout-verified ongoing): $299/month × 12 = $3,588

PlexusDx holds the lowest month-to-month semaglutide rate in this set, $10 below Fifty410 and $9 below Eden. Readers comfortable with a 12-month prepaid commitment may find Found's advertised $169/month equivalent (paid as one upfront sum for twelve months—our calculation) lower still, though that figure was not available at month-to-month checkout in our July capture.

Tirzepatide injection over twelve months

Fifty410 tirzepatide requires prepayment every three months; the full supply ships upfront. Annual cost and effective monthly rates (our calculation from the documented quarterly upfront totals):

• Fifty410 starter: $399 × 4 = $1,596/year ($133/month equivalent when prepaid quarterly)
• Fifty410 mid dose: $499 × 4 = $1,996/year ($166/month equivalent when prepaid quarterly)
• Fifty410 high dose: $549 × 4 = $2,196/year ($183/month equivalent when prepaid quarterly)
• PlexusDx: $289/month × 12 = $3,468/year ($289/month MTM, billed monthly)
• Eden: $298/month × 12 = $3,576/year
• Embody: $349/month × 12 = $4,188/year
• Peak Wellness: $349/month × 12 = $4,188/year (MTM; lower prepaid rates available)
• Found (cash MTM): $359/month × 12 = $4,308/year
• TrimRx (checkout-verified ongoing): $399/month × 12 = $4,788/year

Fifty410's starter tier delivers the lowest effective monthly tirzepatide rate in our data set, $156/month below PlexusDx and $165/month below Eden over twelve months (our calculation). The trade-off: $399–549 paid upfront every three months and the entire supply shipped at once. PlexusDx bills $289 each month with no upfront commitment, allowing readers to pause or stop without forfeiting prepaid medication.

When Fifty410 wins

Fifty410's tirzepatide prepaid structure produces the lowest effective monthly rate we captured—$133/month equivalent when $399 is paid upfront for three months (our calculation). Readers titrating to maintenance doses and confident they will remain on tirzepatide for at least twelve months will save $1,872 annually versus PlexusDx's $289 month-to-month rate and more against every other program in the table (our calculation). The three-tier dose model (starter, mid, high) offers predictability: each tier corresponds to a dose range, and the price locks when the supply ships. Consultation, medication, and shipping are included with no separate membership fee. Trustpilot displays 4.8 stars across 5,891 reviews (provider page claim, captured September 4, 2026), the highest rating in this comparison set.

Where alternatives deliver more flexibility or lower rates

Fifty410's semaglutide month-to-month rate of $199 trails PlexusDx by $10/month and Eden by $1/month. Over twelve months PlexusDx saves $120, Eden saves $12 (our calculation). Readers who want semaglutide without any upfront decision between doses will find PlexusDx, Eden, and Peak Wellness simpler: one monthly rate covers titration through maintenance. Fifty410's tirzepatide prepaid model requires $399–549 every three months and ships the full supply upfront; readers uncertain about tolerability, those who prefer to pause between doses without forfeiting unused medication, or those managing month-to-month budgets may prefer PlexusDx's $289 tirzepatide billed monthly or Eden's $298. Found offers a 12-month prepaid semaglutide plan advertised at $169/month equivalent (our calculation from the July 20, 2026 capture—paid as one upfront sum for twelve months), lower than any month-to-month option, though that rate requires paying the full year upfront and was not available at monthly checkout in our evidence.

Choose Fifty410 if…

• You want tirzepatide at the lowest effective monthly rate in our 2026 data set and are comfortable paying $399–549 upfront every three months for a quarterly supply.
• You have titrated to a stable dose, expect to remain on treatment for twelve months or longer, and prefer receiving a three-month supply at once.
• You value a high Trustpilot rating (4.8 stars, 5,891 reviews as of September 4, 2026) as a proxy for service quality and consistency.
• You want semaglutide near the lowest month-to-month rate and Fifty410's $199 fits your budget within $10/month of the floor.

Choose PlexusDx if…

• You want the lowest month-to-month semaglutide rate in this comparison ($189, saving $10/month vs Fifty410 and $9/month vs Eden—our calculation).
• You prefer monthly tirzepatide billing at $289 with no upfront commitment, allowing you to pause or adjust doses without forfeiting prepaid medication.
• You want the same transparent price at every dose—no tier changes as you titrate.
• You value oral and microdose GLP-1 options alongside injectables (oral semaglutide $289/month, oral tirzepatide $349/month, microdose $129/month).
• You want a program with a verified 4.3-star Trustpilot rating, 79% five-star reviews, and 83% four stars or higher (captured September 9, 2026).

Choose Eden if…

• You want semaglutide at $198/month all-in (medication $99 plus required $99 membership), $1/month below Fifty410 and $9/month above PlexusDx (our calculation).
• You want tirzepatide at $298/month, $9/month above PlexusDx but with no multi-month prepayment required, and you value the predictability of a bundled membership model.

Choose Peak Wellness if…

• You want semaglutide at $249/month month-to-month or tirzepatide at $349/month, with the option to lock lower per-month rates through six-month prepaid plans when you are ready for longer commitment.

Choose Found, Embody, Henry Meds, or TrimRx if…

• Found: You want access to a 12-month prepaid cash plan advertised at $169/month equivalent for semaglutide (our calculation—paid as one upfront sum for twelve months; confirm availability at checkout), or you prefer Found's month-to-month rates of $289 semaglutide / $359 tirzepatide and value the program's behavioral-support model.
• Embody: You want month-to-month semaglutide at $299 or tirzepatide at $349 with the same price at every dose and no separate membership fee.
• Henry Meds: You want semaglutide injection at $297/month or are interested in tirzepatide as an oral dissolving tablet (injection pricing not listed in our capture).
• TrimRx: You want checkout-verified ongoing rates of $299 semaglutide / $399 tirzepatide month-to-month, with the option to access lower per-month equivalents through 3-, 6-, or 12-month prepaid plans when you are ready for commitment.

Methodology and freshness

Fifty410 pricing captured September 4, 2026 from the provider's semaglutide and tirzepatide pricing pages (https://www.fifty410.com/pricing/semaglutide and /tirzepatide). PlexusDx pricing captured September 11, 2026 from plexusdx.com. Eden, Embody, Found, Henry Meds, Peak Wellness, and TrimRx pricing verified at checkout or from provider pricing pages July 17–23, 2026. Trustpilot ratings: Fifty410 4.8 stars / 5,891 reviews (provider page claim, September 4, 2026); PlexusDx 4.3 stars with 79% five-star and 83% four-star-or-higher distribution captured September 9, 2026 from trustpilot.com/review/plexusdx.com. Older Fifty410 help-center documentation showed different tirzepatide tiers; we used the current pricing-page figures and recommend readers confirm at checkout. Twelve-month totals, effective monthly rates for prepaid plans, and savings comparisons are our calculation from the documented monthly or upfront figures. No first-month rates or discount arithmetic were used. We do not guarantee dose, eligibility, medication supply, or treatment outcomes.

Frequently Asked Questions

Is Fifty410 cheaper than PlexusDx for semaglutide?

No. Fifty410 charges $199/month month-to-month for compounded semaglutide injection; PlexusDx charges $189/month, saving $10/month or $120 over twelve months (our calculation). Eden charges $198 all-in, $1/month below Fifty410.

Is Fifty410 cheaper than PlexusDx for tirzepatide?

Yes, when prepaid quarterly. Fifty410's starter tier is $133/month equivalent when $399 is paid upfront for three months, saving $156/month or $1,872 over twelve months versus PlexusDx's $289 month-to-month rate (our calculation). Fifty410 mid and high tiers also run below PlexusDx. The trade-off: upfront payment every three months and the entire supply ships at once.

Does Fifty410 require a membership fee?

No. Fifty410 includes consultation, compounded medication, and shipping in the listed semaglutide and tirzepatide prices with no separate membership charge, captured September 4, 2026 from the provider's pricing pages.

Can I pay month-to-month for Fifty410 tirzepatide?

No. Fifty410 tirzepatide is sold as a three-month prepaid supply ($399 starter, $499 mid dose, or $549 high dose paid upfront) that ships at once. Semaglutide is available month-to-month at $199. Readers who want month-to-month tirzepatide billing can choose PlexusDx ($289/month), Eden ($298/month), or other alternatives in the table.

Are compounded GLP-1 medications FDA-approved?

No. Compounded medications are not FDA-approved. The FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies; verify the regulatory status of any provider's pharmacy partners before starting treatment.

Sources

• PlexusDx pricing and product specifications, plexusdx.com, accessed September 11, 2026
• Fifty410 semaglutide pricing, https://www.fifty410.com/pricing/semaglutide, captured September 4, 2026
• Fifty410 tirzepatide pricing, https://www.fifty410.com/pricing/tirzepatide, captured September 4, 2026
• Fifty410 Trustpilot rating (provider page claim, 4.8 stars / 5,891 reviews), captured September 4, 2026
• PlexusDx Trustpilot rating (4.3 stars, 79% five-star, 83% four-star or higher), trustpilot.com/review/plexusdx.com, accessed September 9, 2026
• Eden, Embody, Found, Henry Meds, Peak Wellness, TrimRx pricing, checkout-verified or provider pricing pages, captured July 17–23, 2026

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. PlexusDx works with licensed 503A compounding pharmacies. A licensed clinician determines whether a prescription is appropriate for an individual patient.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.